BookJose Zamorano, Patrizio Lancellotti, Luc Pierard, Philippe Pibarot, editors.
Summary: This book provides a state-of-the-art description of the pathophysiology, diagnosis and management of valvular heart disease (VHD). With an aging population, the incidence and complexity of VHD has markedly increased and the introduction of transcatheter valve therapies have revolutionized the management of these frequent and serious cardiovascular diseases. The development of percutaneous valve interventions has revolutionized the management of VHD (or has dramatically changed its management) Heart Valve Disease: State of the Art is dedicated to provide up-to-date knowledge to clinical and interventional cardiologists, cardiovascular imagers and cardiac surgeons. It provides state-of-the-art information for the health-care professional working in heart valve clinics, heart teams, and centers of excellence that specialize in managing patients with heart valve disease.
Contents:
Intro; Preface; Acknowledgements; Contents;
1: Introduction to Valve Heart Disease; Etiology of Valve Heart Disease; Rheumatic Fever; Calcific Valve Disease; Endomyocardial Fibrosis; Infectious Endocarditis; Valve Fibrous Structure Dilation; Chronic Systemic Inflammatory Disorders; Congenital Diseases; Drugs; Heart Valve Clinic; Models of Heart Valve Clinic; Available Evidence Regarding HVC; References;
2: Evaluation of Patients with Heart Valve Disease; Echocardiographic Evaluation of Valvular Heart Disease; Assessment of Valve Anatomy; Evaluation of Stenosis Severity Evaluation of Valvular RegurgitationEvaluation of Left Ventricular Geometry and Function; Right Heart Structure and Function; Aortic Anatomy; Prosthetic Valves and Infective Endocarditis; Other Echocardiographic Data; LV Diastolic Function and Filling Pressure; Pulmonary Pressures; References;
3: Aortic Stenosis; Introduction; Etiology and Epidemiology; Pathophysiology and Risk Factors; Pathophysiology of Calcific AS; Risk Factors and Potential Therapeutic Targets; Clinical Risk Factors; Genetic Risk Factors; Pathophysiology of LV Dysfunction and Symptoms in AS; Diagnosis and Management Grading AS SeverityAt Risk for AS (Grade 0 or Stage A); Mild or Moderate AS (Grades 1 and 2 or Stage B); Asymptomatic Severe AS (Grade 3 or Stage C); Symptomatic Severe AS (Grade 4 or Stage D); Discordant Grading with Low-Gradient AS; Staging Cardiac Damage; Selecting Surgical Versus Transcatheter Aortic Valve Replacement; Conclusions; References;
4: Aortic Regurgitation; Acute Aortic Regurgitation; Aetiology; Pathophysiology; Clinical presentation; Diagnosis; Management; Chronic Aortic Regurgitation; Aetiology; Pathophysiology; Clinical Presentation; Symptoms; Physical Examination; ECG Chest RadiographyDiagnosis; Transthoracic Echocardiography; TEE Examination; Other Imaging Modalities; Others; Natural History; Management; Follow-Up; References;
5: Aortic Valve Intraoperative Echocardiography; Transcatheter Aortic Valve Replacement (TAVR); Guiding the Procedure; Transapical Aortic Valve Replacement; Aortic Valve Repair; Reparability Assessment; Intraoperative TEE; Endocarditis; Paravalvular Leak Closure; Guiding the Procedure; References;
6: Mitral Stenosis; Aetiology; Physiopathology; Diagnosis; Symptoms; Physical Examination; Echocardiography; Positive Diagnosis MS Morphology Assessment by EchocardiographyQuantification of Severity; The Doppler Volumetric Method; The Proximal Isovelocity Surface Area (PISA) Method; Consequencies of MS; Exercise Testing/Stress Echocardiography; Catheterization; Medical Treatment; Percutaneous Mitral Commissurotomy (PMC); Surgical Procedures; Follow Up; References;
7: Mitral Regurgitation; Pathogenesis; Epidemiology; Aetiology; Primary Mitral Regurgitation; Secondary Mitral Regurgitation; Physiopathology; Clinical Presentation; Physical Examination; Diagnosis; Defining the Mechanism of Mitral Valve Insufficiency